ArticleCancer biology & therapy2018

Correlation of trastuzumab-based treatment with clinical characteristics and prognosis in HER2-positive gastric and gastroesophageal junction cancer: A retrospective single center analysis.

A Ilhan-Mutlu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.